As of 4:00pm ET
| +0.05 / +1.45%|
The 4 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 11.25 and a low estimate of 3.00. The median estimate represents a +100.00% increase from the last price of 3.50.
The current consensus among 5 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.